Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Flatt

Showing results (101-110 of 325) with videos related to

Pageof 33
Sort By:
Peptides|November 26, 2008
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intoleranceBarry D Kerr, Nigel Irwin, Peter R Flatt, et al.
Journal of Molecular Endocrinology|December 21, 2014
Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cellsSrividya Vasu, R Charlotte Moffett, Neville H McClenaghan, et al.
Peptides|December 27, 2021
Classical and non-classical islet peptides in the control of β-cell functionDawood Khan, R Charlotte Moffett, Peter R Flatt, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|June 28, 2019
Effects of 2 Novel PYY(1-36) Analogues, (P<sup>3</sup>L<sup>31</sup>P<sup>34</sup>)PYY(1-36) and PYY(1-36)(Lys<sup>12</sup>PAL), on Pancreatic Beta-Cell Function, Growth, and SurvivalRyan A Lafferty, Victor A Gault, Peter R Flatt, et al.
The Journal of Endocrinology|October 12, 2012
Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal miceNigel Irwin, Pamela Frizelle, Finbarr P M O'Harte, et al.
Biochimica Et Biophysica Acta|September 6, 2013
Mechanisms of toxicity by proinflammatory cytokines in a novel human pancreatic beta cell line, 1.1B4Srividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
Islets|August 30, 2013
Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemiaSrividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
The Journal of Endocrinology|August 6, 2013
Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptorGuillaume Mabilleau, Aleksandra Mieczkowska, Nigel Irwin, et al.
The Journal of Biological Chemistry|October 30, 2013
A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed miceVictor A Gault, Vikas K Bhat, Nigel Irwin, et al.
Biochimie|March 27, 2016
Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxinsAlastair D Green, Srividya Vasu, R Charlotte Moffett, et al.
Pageof 33

Showing results (101-110 of 325) with videos related to

Sort By:
Pageof 33
Peptides|November 26, 2008
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intoleranceBarry D Kerr, Nigel Irwin, Peter R Flatt, et al.
Journal of Molecular Endocrinology|December 21, 2014
Responses of GLP1-secreting L-cells to cytotoxicity resemble pancreatic β-cells but not α-cellsSrividya Vasu, R Charlotte Moffett, Neville H McClenaghan, et al.
Peptides|December 27, 2021
Classical and non-classical islet peptides in the control of β-cell functionDawood Khan, R Charlotte Moffett, Peter R Flatt, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|June 28, 2019
Effects of 2 Novel PYY(1-36) Analogues, (P<sup>3</sup>L<sup>31</sup>P<sup>34</sup>)PYY(1-36) and PYY(1-36)(Lys<sup>12</sup>PAL), on Pancreatic Beta-Cell Function, Growth, and SurvivalRyan A Lafferty, Victor A Gault, Peter R Flatt, et al.
The Journal of Endocrinology|October 12, 2012
Metabolic effects of activation of CCK receptor signaling pathways by twice-daily administration of the enzyme-resistant CCK-8 analog, (pGlu-Gln)-CCK-8, in normal miceNigel Irwin, Pamela Frizelle, Finbarr P M O'Harte, et al.
Biochimica Et Biophysica Acta|September 6, 2013
Mechanisms of toxicity by proinflammatory cytokines in a novel human pancreatic beta cell line, 1.1B4Srividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
Islets|August 30, 2013
Cellular responses of novel human pancreatic β-cell line, 1.1B4 to hyperglycemiaSrividya Vasu, Neville H McClenaghan, Jane T McCluskey, et al.
The Journal of Endocrinology|August 6, 2013
Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptorGuillaume Mabilleau, Aleksandra Mieczkowska, Nigel Irwin, et al.
The Journal of Biological Chemistry|October 30, 2013
A novel glucagon-like peptide-1 (GLP-1)/glucagon hybrid peptide with triple-acting agonist activity at glucose-dependent insulinotropic polypeptide, GLP-1, and glucagon receptors and therapeutic potential in high fat-fed miceVictor A Gault, Vikas K Bhat, Nigel Irwin, et al.
Biochimie|March 27, 2016
Co-culture of clonal beta cells with GLP-1 and glucagon-secreting cell line impacts on beta cell insulin secretion, proliferation and susceptibility to cytotoxinsAlastair D Green, Srividya Vasu, R Charlotte Moffett, et al.
Pageof 33